Blog

How PACEĀ® Facilitated Discovery of a New Sweetness QTL in White Lupin — Supporting the Crop’s Expanding Role in Food and Feed

How PACEĀ® Facilitated Discovery of a New Sweetness QTL in White Lupin — Supporting the Crop’s Expanding Role in Food and Feed

Organisation: Research Institute of Organic Agriculture (FiBL) & collaborators
Industry: Plant Breeding, Crop Genetics, Sustainable Protein Systems
3CR Contribution: Custom PACEĀ® assay design + PACEĀ® Master Mix for high-throughput genotyping
Study: Patyi et al., 2025 (BMC Plant Biology)

White lupin (Lupinus albus) is gaining renewed attention as a high-protein, low-input crop suited for sustainable farming. Historically used in niche horticultural systems, lupins are now being recognised for their role in both animal feed and human food markets.

In animal feed, lupins provide a sustainable alternative protein source, with seeds containing 33–47% protein. Their deep roots improve soil structure and nutrient cycling, supporting regenerative and organic systems. Farmers benefit by:

  • Diversifying forage
  • Reducing feed costs
  • Increasing home-grown protein independence
  • Supporting low-input, sustainable livestock systems

Human food applications are also expanding. Lupin flour is used in gluten-free baking, plant-based dairy alternatives, and protein-enriched foods. Its high fibre, omega-3 content and low starch make it attractive for health-conscious consumers.

The main barrier to wider adoption remains quinolizidine alkaloids (QAs) — bitter, potentially toxic compounds. Modern ā€œsweetā€ varieties exist, but environmental variability can still push QA levels above safe thresholds. Breeders need reliable ultra-low-QA varieties to unlock lupin’s full potential.

How 3CR Supported the Project

FiBL aimed to identify new low-QA genetics beyond the well-known recessive pauper allele.

This required tracking sweetness alleles across hundreds of breeding lines, including:

  • 112 F2 plants
  • 329 F3 plants
  • 34 diverse lupin accessions for validation.

3CR supported the study with:

  • Custom PACEĀ® assays for four key SNPs
  • PACEĀ® Master Mix for all genotyping reactions
  • Primer design optimised via 3CR’s free assay design service

PACEĀ® was selected for its:

  • Affordability and high specificity
  • Compatibility with unlabelled primers
  • Scalability to hundreds or thousands of samples
  • Flexibility with different DNA types, including FTA cards

This enabled a fast, cost-effective workflow suitable for large-scale breeding populations.

Key Discoveries

Using bulked segregant analysis, researchers identified a 1 Mb QTL on chromosome 5 linked to low QA, independent of pauper. PACEĀ® assays validated SNPs in this region and the marker Lalb_Chr05_6643621 emerged as the strongest predictor for the new sweetness locus.

By stacking the pauper allele with the new chromosome 5 sweetness allele, researchers achieved:

  • QA levels of 22.8 ± 10.4 ppm — ~10Ɨ below the safe threshold for human consumption
  • One of the lowest alkaloid levels ever recorded in white lupin
  • A dramatically simplified alkaloid profile

These ultra-low-QA lines provide reliably sweet lupin suitable for both animal feed and food markets.

Impact on Feed and Forage

The breakthrough delivers tangible benefits for the feed and forage sector:

  • Safer feed formulations: Lower QA levels improve palatability and digestibility for pigs and poultry.
  • Cost reduction: Reduced need for debittering decreases costs and environmental impact.
  • Support for local protein: Low-QA lupins can replace imported soy, enhancing self-sufficiency.
  • Enhanced rotational value: Wider adoption improves soil fertility, biodiversity, nitrogen fixation, and forage system resilience.

By enabling breeders to select for sweetness reliably, PACEĀ® directly supports the expansion of lupin as a mainstream protein crop.

Why It Matters

With the global shift toward sustainable protein, lupins are uniquely positioned to fill nutritional gaps if alkaloid levels are tightly controlled. This study demonstrates how 3CR’s PACEĀ® assays allow breeders to:

  • Identify new sweetness genetics
  • Stack alleles effectively
  • Develop ultra-low-alkaloid cultivars
  • Accelerate lupin adoption across food, feed and forage markets

PACEĀ® helped FiBL uncover new sweetness genetics in white lupin, unlocking safer, ultra-low-alkaloid varieties that support the crop’s growing role in sustainable agriculture.

MORE POSTS

Automated Pipetting vs. Manual Pipetting: Which Is Right for Your Lab?
Discover when manual pipetting is enough—and why automated pipetting with 3CR’s GeneArrayer and PACEĀ® genotyping delivers superior speed, accuracy, and scalability.
High-Throughput PCR in CRISPR Screening and Genome Editing Verification
Discover how high-throughput PCR using PACEĀ® genotyping accelerates CRISPR screening and genome editing verification across large sample populations.
Understanding the genetics of important traits in hemp to help breed improved cultivars
Learn how Cornell University uses PACEĀ® SNP genotyping to accelerate hemp breeding—enabling early trait selection, sex determination, and cost-effective genetic screening.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACEĀ® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR.Ā 

Sign up now to receive insights, updates 
and industry case studies.Ā 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACEĀ®, ProbeSure, KASPā„¢, KlearKall, KlearGene, KlearAmp and KlearTaqā„¢, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.